Product Program year 2020 Source: CMS Open Payments

Mk-7684

Drug Oncology

Open in the dashboard

General payments

$178,180

65 payments

Research payments

$7,751,454

2,502 payments

Through program year 2020, $178,180 in general payments and $7,751,454 in research payments were reported against Mk-7684 (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $74,425 36
2020 Research $3,428,063 2,189
2019 General $103,755 29
2019 Research $4,323,391 313

Breakdown

Who paid General payments · program years 2019–2020
  1. Merck Sharp & Dohme Corporation $178,180 65 payments
Top recipients General payments · program year 2020
  1. Ronald Arellano Vascular & Interventional Radiology · Boston, MA $27,115 36% · 12 payments
  2. Joanne Wernicki Diagnostic Radiology · Vero Beach, FL $22,050 30% · 10 payments
  3. Mukesh Harisinghani Diagnostic Radiology · Boston, MA $13,260 18% · 9 payments
  4. Karl Feuerlein Diagnostic Radiology · Tampa, FL $12,000 16% · 5 payments

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Diagnostic Radiology Radiology $47,310 64% · 3 practitioners
  2. Vascular & Interventional Radiology Radiology $27,115 36% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Massachusetts $40,375 54% · 2 recipients
  2. Florida $34,050 46% · 2 recipients

Each share is of general payments naming this product in 2020 where a state was reported.

65 general · 2,502 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record